TABLE 1

Characteristics of patients who started monitoring in the different study arms

Characteristics at GP consultation	Study arm
Characteristics at GP consultation	Dexamethasone	Control group
Subjects, n	4	2
Male sex	3 (75)	2 (100)
Age group
<65 years	2 (50)	1 (50)
≥65 years	2 (50)	1 (50)
Obesity (BMI ≥30 kg·m⁻²)	2 (50)	0 (0)
Asthma	2 (50)	0 (0)
COPD	1 (25)	0 (0)
Cardiovascular disease	1 (25)	1 (50)
Diabetes mellitus	1 (25)	1 (50)
Dyspnoea degree
None or mild	2 (50)	0 (0)
Moderate	1 (25)	2 (100)
Severe	1 (25)	0 (0)
Temperature ≥38.0°C	2 (50)	0 (0)
S_pO₂ at rest^#, %	99/97/94/93	94/92
S_pO₂ after STS^#, %	95/92/90/89	88/91
Outcome
Time to recovery, days^#,¶	>28/>28/NA/NA	14/8
Severe COVID-19^#	Yes/No/Yes/Yes	No/No

Data are presented as n (%), unless otherwise stated. BMI: body mass index; S_pO₂: peripheral oxygen saturation; STS: sit-to-stand test; NA: not available due to hospital admission. ^#: individual values; ^¶: defined as self-reported recovery for at least 2 consecutive days.